Dr. Brandon Lenox
Claim this profileK2 Medical Research
Studies Alzheimer's Disease
Studies Aggression
9 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Brandon Lenox is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
LY3954068
for Alzheimer's Disease
The main purpose of this study is to evaluate the safety of LY3954068 in participants with early symptomatic Alzheimer's Disease (AD). The study will also investigate how much LY3954068 gets into the bloodstream and will test the effects of LY3954068 on markers of AD. The study will be comprised of two parts, A and B. Part B is optional, and participants from Part A may also have the opportunity to join an optional bridging period to a separate potential study where participants would receive LY3954068. Each enrolled participant in Part A will receive a single dose of LY3954068 or placebo (no active drug) given into the spinal fluid. If conducted, each participant in Part B would receive 2 doses of either LY3954068 or placebo administered into the spinal fluid. The study will last up to approximately 45 weeks for Part A, and, if conducted, 73 weeks for Part B, including the screening period. If the optional bridging period is conducted, participants in Part A could be enrolled in the separate potential study for up to approximately 96 weeks, including the screening period.
Recruiting0 awards Phase 1
More about Brandon Lenox
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Brandon Lenox has experience with
- Placebo
- ALZ-801
- Donanemab
- BTRX-335140
- LY3372689
- Remternetug (IV)
Breakdown of trials Brandon Lenox has run
Alzheimer's Disease
Aggression
Agitation
Agitation in Dementia
Agitation or Aggression
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brandon Lenox specialize in?
Brandon Lenox focuses on Alzheimer's Disease and Aggression. In particular, much of their work with Alzheimer's Disease has involved APOE ε4 positive patients, or patients who are undergoing treatment.
Is Brandon Lenox currently recruiting for clinical trials?
Yes, Brandon Lenox is currently recruiting for 4 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Brandon Lenox has studied deeply?
Yes, Brandon Lenox has studied treatments such as Placebo, ALZ-801, Donanemab.
What is the best way to schedule an appointment with Brandon Lenox?
Apply for one of the trials that Brandon Lenox is conducting.
What is the office address of Brandon Lenox?
The office of Brandon Lenox is located at: K2 Medical Research, Orlando, Florida 32751 United States. This is the address for their practice at the K2 Medical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.